ConvaTec logo

CTEC - ConvaTec News Story

224p 0.0  0.0%

Last Trade - 4:35pm

Sector
Healthcare
Size
Large Cap
Market Cap £4.51bn
Enterprise Value £5.27bn
Revenue £1.46bn
Position in Universe 199th / 1783

ConvaTec Group PLC - Director/PDMR Shareholding

Fri 30th July, 2021 3:45pm
RNS Number : 1280H
ConvaTec Group PLC
30 July 2021
 

30 July 2021

ConvaTec Group Plc
("ConvaTec" or "the Company")
Director/PDMR Shareholding

The Company has been notified of the following transaction by a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

On 30 July 2021, Professor Constantin Coussios, Non-Executive Director and a PDMR, purchased 8,440 Shares at £2.356227 per share. His resulting shareholding is 8,440 Shares.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Professor Constantin Coussios

2

Reason for the notification

a)

Position/Status

Non-Executive Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

ConvaTec Group Plc

b)

LEI

213800LS272L4FIDOH92

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in ConvaTec Group Plc ("Shares")

GB00BD3VFW73

b)

Nature of the transaction

  Purchase of Shares on 30 July 2021

 

c)

Price(s) and volume(s)

Price(s)

2.356227

Volume(s)

8,440

d)

Aggregated information

- Aggregated volume 

- Price

 

8,440

19,886.56

e)

Date of the transaction

2021-07-30

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)






 

Enquiries

Analysts and Investors

Kate Postans, VP of IR & Corporate Communications                          +44 (0)782 644 7807

ir@convatec.com

 

Media

Buchanan: Charles Ryland / Chris Lane / Vicky Hayns                         +44 (0)207 466 5000                                                                                                       

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFSSDFIIVIL
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.